What does this decision mean?
Lack of confirmed quality of the active substance used for batch 25D052 and non-compliance with GMP requirements in the supply chain. The product is a solution for infusion, so potential quality deviations carry an increased risk to patients' health and life. Potential effects: poisoning, lack of efficacy, complications during intravenous therapy.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
A recall means the product may be unsafe. Here is what to do if you have it at home.
Do not eat or use the product
Stop using or consuming it immediately and keep it out of reach of children.
Check the batch number and expiry date
Compare the batch/lot number and the best-before or expiry date with the details in the alert — sometimes only specific batches are affected.
Return it to the shop
You can take the product back to the shop where you bought it. For a safety recall a refund is due even without a receipt.
Get help and report it
If you feel unwell after using the product, contact a doctor. You can also report the case to the relevant authority — GIS, GIF or UOKiK.
General guidance for recalled products in Poland. Always follow the specific instructions in the official alert and from the manufacturer or retailer.
Important Information
Do not use Clarithromycin hameln 500 mg from batch 25D052. Check the batch number on the package before using the medicine. If you have packages from this batch, return them to a pharmacy or consult y...
Withdrawal from the market throughout the entire country of Clarithromycin hameln 500 mg, powder for concentrate for solution for infusion, batch 25D052. Ban on placing batch 25D052 on the market. The...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.